Aneurysmal Subarachnoid Hemorrhage Onset Alters Pyruvate Metabolism in Poor-Grade Patients and Clinical Outcome Depends on More: A Cerebrospinal Fluid Metabolomic Study.


Journal

ACS chemical neuroscience
ISSN: 1948-7193
Titre abrégé: ACS Chem Neurosci
Pays: United States
ID NLM: 101525337

Informations de publication

Date de publication:
20 03 2019
Historique:
pubmed: 7 12 2018
medline: 1 4 2020
entrez: 7 12 2018
Statut: ppublish

Résumé

Cerebral metabolism alterations influence cerebrospinal fluid (CSF) composition and are sensitive to brain injury. In subarachnoid hemorrhage (SAH) patients, Fisher scale, Hunt-Hess scale, and World Federation of Neurological Societies (WFNS) grading scale evaluating SAH severity are inadequate to predict long-term outcome; therefore, in an effort to determine metabolite pattern disparity and discover corresponding biomarkers, we designed an untargeted CSF metabolomic study covering a broad range of metabolites of SAH patients with different severity and outcome. The present study demonstrated the SAH altered the cerebrospinal fluid metabolome involving carbohydrate, lipid, and amino acid metabolism. Pyruvate metabolism was enhanced in SAH patients with Hunt-Hess scale above III, and the CSF pyruvate level was significantly associated with WFNS grading scale above III. There is no significant variation among CSF metabolome in SAH patients with merely different amounts and distribution of bleeding. SAH patients with unfavorable outcome present upregulated CSF amino acids level and enhanced lipid biosynthesis. The present study provides a novel possibility of early identification of patients who might possess unfavorable outcome and further clarification of the underlying pathophysiology.

Identifiants

pubmed: 30521753
doi: 10.1021/acschemneuro.8b00581
doi:

Substances chimiques

Biomarkers 0
Pyruvic Acid 8558G7RUTR

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1660-1667

Auteurs

Yi-Chen Li (YC)

Department of Pharmacy , Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School , Nanjing , China 210008.
Department of Neurosurgery , Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School , Nanjing , China 210008.

Rong Wang (R)

Department of Neurosurgery , Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School , Nanjing , China 210008.

Man-Man Xu (MM)

Department of Neurosurgery , Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School , Nanjing , China 210008.
Department of Neurology , Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School , Nanjing , China 210008.

Xiang-Ru Jing (XR)

Department of Neurosurgery , Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School , Nanjing , China 210008.
Nanjing Yuequn Hospital , 158 South Jiefang Road , Nanjing , China 210007.

Ji-Ye A (JY)

Key Laboratory of Drug Metabolism and Pharmacokinetics , China Pharmaceutical University , Nanjing , China 210009.

Run-Bin Sun (RB)

Key Laboratory of Drug Metabolism and Pharmacokinetics , China Pharmaceutical University , Nanjing , China 210009.

Shi-Jie Na (SJ)

Department of Neurosurgery , Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School , Nanjing , China 210008.

Tao Liu (T)

Department of Neurosurgery , Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School , Nanjing , China 210008.

Xuan-Sheng Ding (XS)

Department of Basic Medicine and Clinical Pharmacy , China Pharmaceutical University , Nanjing , China 210009.

Cui-Yun Sun (CY)

Department of Neurosurgery , Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School , Nanjing , China 210008.
Department of Rehabilitation , Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School , Nanjing , China 210008.

Wei-Hong Ge (WH)

Department of Pharmacy , Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School , Nanjing , China 210008.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH